2024 annual financial data
Cytosorbents 2024 Net margin
Direct answer
Net margin was -58.21%.
Operating income was -16,452,000 USD and net income was -20,718,957 USD.
Operating cash flow was -14,427,809 USD.
Get free Cytosorbents email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 35,595,000 USD
- Operating income
- -16,452,000 USD
- Net income
- -20,718,957 USD
- Operating cash flow
- -14,427,809 USD